1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      NPASS database update 2023: quantitative natural product activity and species source database for biomedical research

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Quantitative activity and species source data of natural products (NPs) are important for drug discovery, medicinal plant research, and microbial investigations. Activity values of NPs against specific targets are useful for discovering targeted therapeutic agents and investigating the mechanism of medicinal plants. Composition/concentration values of NPs in individual species facilitate the assessments and investigations of the therapeutic quality of herbs and phenotypes of microbes. Here, we describe an update of the NPASS natural product activity and species source database previously featured in NAR. This update includes: (i) new data of ∼95 000 records of the composition/concentration values of ∼1 490 NPs/NP clusters in ∼390 species, (ii) extended data of activity values of ∼43 200 NPs against ∼7 700 targets (∼40% and ∼32% increase, respectively), (iii) extended data of ∼31 600 species sources of ∼94 400 NPs (∼26% and ∼32% increase, respectively), (iv) new species types of ∼440 co-cultured microbes and ∼420 engineered microbes, (v) new data of ∼66 600 NPs without experimental activity values but with estimated activity profiles from the established chemical similarity tool Chemical Checker, (vi) new data of the computed drug-likeness properties and the absorption, distribution, metabolism, excretion and toxicity (ADMET) properties for all NPs. NPASS update version is freely accessible at http://bidd.group/NPASS.

          Related collections

          Most cited references55

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation

          The Interactive Tree Of Life ( https://itol.embl.de ) is an online tool for the display, manipulation and annotation of phylogenetic and other trees. It is freely available and open to everyone. iTOL version 5 introduces a completely new tree display engine, together with numerous new features. For example, a new dataset type has been added (MEME motifs), while annotation options have been expanded for several existing ones. Node metadata display options have been extended and now also support non-numerical categorical values, as well as multiple values per node. Direct manual annotation is now available, providing a set of basic drawing and labeling tools, allowing users to draw shapes, labels and other features by hand directly onto the trees. Support for tree and dataset scales has been extended, providing fine control over line and label styles. Unrooted tree displays can now use the equal-daylight algorithm, proving a much greater display clarity. The user account system has been streamlined and expanded with new navigation options and currently handles >1 million trees from >70 000 individual users. Graphical Abstract iTOL: an online tool for the tree display and annotation.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Lead- and drug-like compounds: the rule-of-five revolution.

            Citations in CAS SciFinder to the rule-of-five (RO5) publication will exceed 1000 by year-end 2004. Trends in the RO5 literature explosion that can be discerned are the further definitions of drug-like. This topic is explored in terms of drug-like physicochemical features, drug-like structural features, a comparison of drug-like and non-drug-like in drug discovery and a discussion of how drug-like features relate to clinical success. Physicochemical features of CNS drugs and features related to CNS blood-brain transporter affinity are briefly reviewed. Recent literature on features of non-oral drugs is reviewed and how features of lead-like compounds differ from those of drug-like compounds is discussed. Most recently, partly driven by NIH roadmap initiatives, considerations have arisen as to what tool-like means in the search for chemical tools to probe biology space. All these topics frame the scope of this short review/perspective.: © 2004 Elsevier Ltd . All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Natural products in drug discovery: advances and opportunities

              Natural products and their structural analogues have historically made a major contribution to pharmacotherapy, especially for cancer and infectious diseases. Nevertheless, natural products also present challenges for drug discovery, such as technical barriers to screening, isolation, characterization and optimization, which contributed to a decline in their pursuit by the pharmaceutical industry from the 1990s onwards. In recent years, several technological and scientific developments — including improved analytical tools, genome mining and engineering strategies, and microbial culturing advances — are addressing such challenges and opening up new opportunities. Consequently, interest in natural products as drug leads is being revitalized, particularly for tackling antimicrobial resistance. Here, we summarize recent technological developments that are enabling natural product-based drug discovery, highlight selected applications and discuss key opportunities.
                Bookmark

                Author and article information

                Contributors
                Journal
                Nucleic Acids Res
                Nucleic Acids Res
                nar
                Nucleic Acids Research
                Oxford University Press
                0305-1048
                1362-4962
                06 January 2023
                29 November 2022
                29 November 2022
                : 51
                : D1
                : D621-D628
                Affiliations
                Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy , Shanghai 201203, China
                Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy , Shanghai 201203, China
                Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy , Shanghai 201203, China
                Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy , Shanghai 201203, China
                Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy , Shanghai 201203, China
                Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy , Shanghai 201203, China
                Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy , Shanghai 201203, China
                Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy , Shanghai 201203, China
                Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy , Shanghai 201203, China
                Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy , Shanghai 201203, China
                Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy , Shanghai 201203, China
                The State Key Laboratory of Chemical Oncogenomics & Key Laboratory of Chemical Biology, Tsinghua University Shenzhen Graduate School, Shenzhen Kivita Innovative Drug Discovery Institute , China
                Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Institute of Drug Discovery Technology, Ningbo University , Ningbo 315211, China
                Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Institute of Drug Discovery Technology, Ningbo University , Ningbo 315211, China
                Medical College, Tibet University , Lhasa 850000, China
                Key Lab of Agricultural Products Processing and Quality Control of Nanchang City, Jiangxi Agricultural University , Nanchang 330045, China
                Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy , Shanghai 201203, China
                Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy , Shanghai 201203, China
                Shenzhen Bay Laboratory , Shenzhen 518000, China
                Author notes
                To whom correspondence should be addressed. Tel: +86 755 26032094; Email: chenyuzong@ 123456sz.tsinghua.edu.cn
                Correspondence may also be addressed to Xian Zeng. Tel: +86 51980035; Email: zengxian@ 123456fudan.edu.cn
                Correspondence may also be addressed to Dianwen Ju. Tel: +86 51980037; Email: dianwenju@ 123456fudan.edu.cn

                The authors wish it to be known that, in their opinion, first four authors should be regarded as Joint First Authors.

                Author information
                https://orcid.org/0000-0003-1654-5550
                https://orcid.org/0000-0002-5473-8022
                Article
                gkac1069
                10.1093/nar/gkac1069
                9825494
                36624664
                cd85e608-21cd-4652-a025-14be7fc2b827
                © The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@ 123456oup.com

                History
                : 26 October 2022
                : 16 October 2022
                : 15 September 2022
                Page count
                Pages: 8
                Funding
                Funded by: Shanghai Sailing Program;
                Award ID: 20YF1402700
                Funded by: National Natural Science Foundation of China, DOI 10.13039/501100001809;
                Award ID: 32000479
                Funded by: State Key Laboratory of Chemical Oncogenomics;
                Funded by: National Key Research and Development Program of China, DOI 10.13039/501100012166;
                Award ID: 2019YFA0905900
                Funded by: Scientific Research Grant of Ningbo University;
                Award ID: 215-432000282
                Funded by: Ningbo Top Talent Project;
                Award ID: 215-432094250
                Funded by: Shenzhen Bay Laboratory, DOI 10.13039/501100021177;
                Award ID: 201901
                Funded by: China Postdoctoral Science Foundation, DOI 10.13039/501100002858;
                Award ID: 2021M690714
                Categories
                AcademicSubjects/SCI00010
                Database Issue

                Genetics
                Genetics

                Comments

                Comment on this article